Zilinskas and Balint and their contributors examine the divisions between minority groups and the scientific community, particularly in the area of medical and genetic research. Minorities have reasons to be skeptical of medical research in general and genetics research in particular. The sad history of the Tuskegee experiment, in which black men with syphilis were left untreated so that the course of the disease could be studied, undermined confidence in the ethics of medical researchers. More recently, publication of "The Bell Curve" reanimated controversy over purported genetic distinctions among the races that could have powerfully negative social implications.

In contrast, as the essays make clear, the Human Genome Project, conducted in accordance with the highest ethical standards, has the potential to make dramatic positive contributions to the health of all human beings. Members of minority communities in particular--who statistically are at high risk of adverse health outcomes in the United States--have much to gain from innovative medical diagnostics and therapies that will result from the study of human genetics. Therefore, if we are to benefit fully from this new knowledge, it is vital that the distrust, skepticism, and misconceptions relating to genetics research be overcome. This is a provocative collection for scholars, students, researchers, and community leaders involved with minority and public health issues.

In the paper we propose a model of tax incentives optimization for inve- ment projects with a help of the mechanism of accelerated depreciation. Unlike the tax holidays which influence on effective income tax rate, accelerated - preciation affects on taxable income. In modern economic practice the state actively use for an attraction of - vestment into the creation of new enterprises such mechanisms as accelerated depreciation and tax holidays. The problem under our consideration is the following. Assume that the state (region) is interested in realization of a certain investment project, for ex- ple, the creation of a new enterprise. In order to attract a potential investor the state decides to use a mechanism of accelerated tax depreciation. The foll- ing question arise. What is a reasonable principle for choosing depreciation rate? From the state's point of view the future investor's behavior will be rat- nal. It means that while looking at economic environment the investor choose such a moment for investment which maximizes his expected net present value (NPV) from the given project. For this case both criteria and "investment rule" depend on proposed (by the state) depreciation policy. For the simplicity we will suppose that the purpose of the state for a given project is a maximi- tion of a discounted tax payments into the budget from the enterprise after its creation. Of course, these payments depend on the moment of investor's entry and, therefore, on the depreciation policy established by the state.

Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits provides a comprehensive, multidisciplinary overview of the environmental, economic, and regulatory implications of advances in marine biotechnology. The book has been specifically designed to bridge the gap between the rapidly advancing marine biotechnology industry and the government agencies that are responsible for risk assessment and regulation. Editors Raymond Zilinskas and Peter Balint have brought together experts in risk assessment, marine ecology, biotechnology, economics, and the law, to provide a unique way of examining complex issues in marine biotechnology. The contributors present innovative and challenging recommendations for protecting public health and the environment, while encouraging the development of beneficial new products in the field of marine biotechnology. As an added feature, each chapter includes a comprehensive, up-to-date bibliography. Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits will prove invaluable to students, researchers and public employees involved with risk assessment. The book will appeal to industry personnel involved with the preparation of marine biotechnology products; scientists and administrators involved with applied research in marine biotechnology; policy analysts concerned with the economics of marine fisheries; and university personnel who focus on the interaction of risk, technology, and public policy.

This is a wide-ranging collection of essays written by experts in the field. The variety of topics provide an interdisciplinary approach to the study of contemporary Mongolia. Topics include the impact of industrialization in Mongolia, environmental policies of the nation, the status of modern biotechnology in Mongolia, Mongolian dairy products, traditional husbandry techniques practised by nomadic people, a description of medicinal plants and their uses in Mongolian traditional medicine, descriptions of unique Mongolian birds, fishes and microbiota, discussion of the fascinating flora and fauna of the Gobi region, and a conservation case-study of the endangered Gobi bear.

This is a wide-ranging collection of essays written by experts in the field. The variety of topics provide an interdisciplinary approach to the study of contemporary Mongolia. Topics include the impact of industrialization in Mongolia, environmental policies of the nation, the status of modern biotechnology in Mongolia, Mongolian dairy products, traditional husbandry techniques practised by nomadic people, a description of medicinal plants and their uses in Mongolian traditional medicine, descriptions of unique Mongolian birds, fishes and microbiota, discussion of the fascinating flora and fauna of the Gobi region, and a conservation case-study of the endangered Gobi bear.

Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits provides a comprehensive, multidisciplinary overview of the environmental, economic, and regulatory implications of advances in marine biotechnology. The book has been specifically designed to bridge the gap between the rapidly advancing marine biotechnology industry and the government agencies that are responsible for risk assessment and regulation. Editors Raymond Zilinskas and Peter Balint have brought together experts in risk assessment, marine ecology, biotechnology, economics, and the law, to provide a unique way of examining complex issues in marine biotechnology. The contributors present innovative and challenging recommendations for protecting public health and the environment, while encouraging the development of beneficial new products in the field of marine biotechnology. As an added feature, each chapter includes a comprehensive, up-to-date bibliography. Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits will prove invaluable to students, researchers and public employees involved with risk assessment. The book will appeal to industry personnel involved with the preparation of marine biotechnology products; scientists and administrators involved with applied research in marine biotechnology; policy analysts concerned with the economics of marine fisheries; and university personnel who focus on the interaction of risk, technology, and public policy.

In the paper we propose a model of tax incentives optimization for inve- ment projects with a help of the mechanism of accelerated depreciation. Unlike the tax holidays which influence on effective income tax rate, accelerated - preciation affects on taxable income. In modern economic practice the state actively use for an attraction of - vestment into the creation of new enterprises such mechanisms as accelerated depreciation and tax holidays. The problem under our consideration is the following. Assume that the state (region) is interested in realization of a certain investment project, for ex- ple, the creation of a new enterprise. In order to attract a potential investor the state decides to use a mechanism of accelerated tax depreciation. The foll- ing question arise. What is a reasonable principle for choosing depreciation rate? From the state's point of view the future investor's behavior will be rat- nal. It means that while looking at economic environment the investor choose such a moment for investment which maximizes his expected net present value (NPV) from the given project. For this case both criteria and "investment rule" depend on proposed (by the state) depreciation policy. For the simplicity we will suppose that the purpose of the state for a given project is a maximi- tion of a discounted tax payments into the budget from the enterprise after its creation. Of course, these payments depend on the moment of investor's entry and, therefore, on the depreciation policy established by the state.

Russian officials claim today that the USSR never possessed an offensive biological weapons program. In fact, the Soviet government spent billions of rubles and hard currency to fund a hugely expensive weapons program that added nothing to the country's security. This history is the first attempt to understand the broad scope of the USSR's offensive biological weapons research-its inception in the 1920s, its growth between 1970 and 1990, and its possible remnants in present-day Russia. We learn that the U.S. and U.K. governments never obtained clear evidence of the program's closure from 1990 to the present day, raising the critical question whether the means for waging biological warfare could be resurrected in Russia in the future. Based on interviews with important Soviet scientists and managers, papers from the Soviet Central Committee, and U.S. and U.K. declassified documents, this book peels back layers of lies, to reveal how and why Soviet leaders decided to develop biological weapons, the scientific resources they dedicated to this task, and the multitude of research institutes that applied themselves to its fulfillment. We learn that Biopreparat, an ostensibly civilian organization, was established to manage a top secret program, code-named Ferment, whose objective was to apply genetic engineering to develop strains of pathogenic agents that had never existed in nature. Leitenberg and Zilinskas consider the performance of the U.S. intelligence community in discovering and assessing these activities, and they examine in detail the crucial years 1985 to 1992, when Mikhail Gorbachev's attempts to put an end to the program were thwarted as they were under Yeltsin.